Elisabeth Kramer

Obere Zahlbacher Str. 67
Mainz, RP 55131, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications

Generation of human induced pluripotent stem cell lines carrying a heterozygous and homozygous PRKD1 c.1774G > A genetic variant causing syndromic congenital defects.

Generation of human induced pluripotent stem cell lines carrying a heterozygous and homozygous PRKD1 c.1774G > A genetic variant causing syndromic congenital defects.

Journal: Stem cell research
Published: December 21, 2025

Corrigendum to "Generation of a biallelic NRAP-knockout mutant from a human iPSC line". [Stem. Cell Res. 88 (2025) 103829].

Corrigendum to "Generation of a biallelic NRAP-knockout mutant from a human iPSC line". [Stem. Cell Res. 88 (2025) 103829].

Journal: Stem cell research
Published: October 01, 2025

Generation of a NRAP-overexpressing mutant from a human iPSC line.

Generation of a NRAP-overexpressing mutant from a human iPSC line.

Journal: Stem cell research
Published: June 30, 2025

Generation of a biallelic NRAP-knockout mutant from a human iPSC line.

Generation of a biallelic NRAP-knockout mutant from a human iPSC line.

Journal: Stem cell research
Published: June 18, 2025

Generation of human induced pluripotent stem cell (hiPSC) lines (UKMi009-A and UKMi011-A) harboring a homozygous and heterozygous HCN4 variant from a family with inherited sinus node dysfunction (SND).

Generation of human induced pluripotent stem cell (hiPSC) lines (UKMi009-A and UKMi011-A) harboring a homozygous and heterozygous HCN4 variant from a family with inherited sinus node dysfunction (SND).

Journal: Stem cell research
Published: January 28, 2025

Chronic Activation of Tubulin Tyrosination Improves Heart Function.

Chronic Activation of Tubulin Tyrosination Improves Heart Function.

Journal: Circulation research
Published: September 16, 2024

Sacubitril/valsartan reduces proteasome activation and cardiomyocyte area in an experimental mouse model of hypertrophy.

Sacubitril/valsartan reduces proteasome activation and cardiomyocyte area in an experimental mouse model of hypertrophy.

Journal: Journal of molecular and cellular cardiology plus
Published: November 03, 2023

Chronic activation of tubulin tyrosination in HCM mice and human iPSC-engineered heart tissues improves heart function.

Chronic activation of tubulin tyrosination in HCM mice and human iPSC-engineered heart tissues improves heart function.

Journal: bioRxiv : the preprint server for biology
Published: June 09, 2023

Generation of a homozygous CRYAB p.Arg120Gly mutant (UKEi001-A-1) from a human iPSC line.

Generation of a homozygous CRYAB p.Arg120Gly mutant (UKEi001-A-1) from a human iPSC line.

Journal: Stem cell research
Published: March 01, 2023

ACTN2 Mutant Causes Proteopathy in Human iPSC-Derived Cardiomyocytes.

ACTN2 Mutant Causes Proteopathy in Human iPSC-Derived Cardiomyocytes.

Journal: Cells
Published: August 09, 2022

Disease modeling of a mutation in α-actinin 2 guides clinical therapy in hypertrophic cardiomyopathy.

Disease modeling of a mutation in α-actinin 2 guides clinical therapy in hypertrophic cardiomyopathy.

Journal: EMBO molecular medicine
Published: June 08, 2022

A Novel miRNA Screen Identifies miRNA-4454 as a Candidate Biomarker for Ventricular Fibrosis in Patients with Hypertrophic Cardiomyopathy.

A Novel miRNA Screen Identifies miRNA-4454 as a Candidate Biomarker for Ventricular Fibrosis in Patients with Hypertrophic Cardiomyopathy.

Journal: Biomolecules
Published: October 04, 2021
Showing 1-12 of 34

Last Updated: 09/26/2026